Skip to main content

Table 1 Demographic and clinical findings of the enrolled pediatric population

From: Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy

 *RIs children
N. evaluated children91
Age (years) (mean/SD*)7.4 ± 2.3
1–3 years old20
3–6 years old42
6–12 years old29
Gender Male/Female47/44
N. of children with family history of atopy/ without family history of atopy49/42
N. of children with allergy/without allergy35/56
N. of children exposed smoke/ unexposed smoke45/46
  1. *RIs recurrent infections, SD standard deviation